| General complication development | Respiratory complications development | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | p | Adj. OR | 95% CI | p | OR | 95% CI | p | Adj. OR | 95% CI | p | |
ASA score > 1 | 2.19 | 1.29–3.73 | 0.003 | 2.22 | 1.30–3.77 | 0.003 | 2.75 | 1.38–5.48 | 0.003 | 2.34 | 1.19–4.73 | 0.017 |
Age (months) | 1.01 | 1.00–1.01 | 0.061 | 1.03 | 0.97–1.08 | 0.281 | 1.01 | 1.0–1.01 | 0.086 | 1.06 | 0.98–1.13 | 0.099 |
Weight (Kg) | 1.01 | 0.99–1.02 | 0.506 |  |  |  | 1.00 | 0.98–1.03 | 0.855 |  |  |  |
Male sex | 1.71 | 1.05–2.78 | 0.028 | 1.73 | 1.07–2.81 | 0.025 | 1.86 | 0.95–3.81 | 0.065 | 1.86 | 0.94–3.71 | 0.074 |
Neuromuscular diseases | 1.49 | 0.58–3.82 | 0.409 |  |  |  | 3.27 | 1.24–8.68 | 0.012 | 3.18 | 1.20–8.41 | 0.020 |
Premedication | 1.07 | 0.60–1.90 | 0.821 |  |  |  | 0.85 | 0.40–1.79 | 0.658 |  |  |  |
Multi-pharmacological anesthesia | 2.87 | 1.24–6.64 | 0.010 | 2.98 | 1.26–7.06 | 0.013 | – | – | – | – | – | – |
Non sevofluorane-based anesthesia | 1.80 | 0.90–3.60 | 0.094 |  |  |  | 0.98 | 0.30–3.22 | 0.969 |  |  |  |
Anesthesia length > 50 min | 1.73 | 1.02–2.91 | 0.039 | 1.62 | 0.96–2.73 | 0.068 | 2.12 | 0.97–4.61 | 0.053 | 1.91 | 0.89–4.10 | 0.097 |
Season autumn-winter | 1.28 | 0.82–1.98 | 0.276 |  |  |  | 1.99 | 1.05–3.76 | 0.031 | 2.01 | 1.06–3.78 | 0.030 |